Blocking or inhibiting the main carbohydrate-stimulated salt absorbing molecules in the small intestine (NHE3, PAT1, and SGLT) and kidney tubules (NHE3, NCC, and ENaC) may significantly blunt the generation of hypertension in individuals with metabolic syndrome. The gene discussed is SLC9A3; the disease is hypertensive disorder.